The Research Source of Truth
for Peptide Compounds

Peer-reviewed molecular data, PubMed-attributed references, and a precision volumetric reconstitution calculator — built for laboratory researchers.

All data is provided for laboratory research purposes only. Not for human or animal consumption. All referenced compounds are research reagents.

77
Compounds Indexed
11
Research Categories
77+
PubMed References
JSON-LD
Schema Markup

Browse by Compound Class

High-Interest Research Compounds

Browse by What You're Studying

Find the right compounds faster. Each goal links directly to the relevant category in the compound library.

Compound Comparisons

Structured mechanism comparisons for the most-searched compound pairs — receptor pharmacology, pharmacokinetics, and published study data.

All comparisons →

Latest from the research blog

Plain-English summaries of recent peptide research, with primary citations.

Abstract mitochondrial network motif representing MOTS-C peptide and NAD+ signaling crosstalk in preclinical metabolic research.
Research Overview10 min read

NAD+ and MOTS-C: Mitochondrial Peptide Research, AMPK Signaling & Metabolic Data | Clinical Peptide

MOTS-C activates AMPK via NAD+ crosstalk in preclinical models. 3 studies, regulatory status, and compound comparison with humanin and SS-31 for researchers.

Jun 10, 2026
Abstract hexagonal molecule motif representing the comparison between BPC-157 pentadecapeptide and KPV tripeptide in gut inflammation research.
Compound Comparison10 min read

BPC-157 vs KPV: Gut Inflammation and Healing Mechanisms in Preclinical Research | Clinical Peptide

BPC-157 and KPV address gut inflammation through distinct pathways — 2 PMIDs reviewed. BPC-157 targets angiogenesis and collagen repair; KPV suppresses NF-κB via melanocortin receptors. See which compound fits your research model.

Jun 9, 2026
Abstract representation of a Phase 2 clinical trial design for BPC-157 pentadecapeptide in musculoskeletal injury research.
Regulatory & Policy11 min read

NCT07437547 BPC-157 Phase 2 Trial: Status, Results & Full Data Summary

NCT07437547 is a Phase 2 randomized controlled trial of BPC-157 for hamstring injury. Current recruiting status, primary endpoints, results posted to date, sponsor details, and connection to the July 2026 FDA PCAC review.

Jun 9, 2026
Abstract diagram of the hypothalamic-pituitary-gonadal axis illustrating gonadorelin and HCG receptor targets in LH/FSH research.
Compound Comparison10 min read

Gonadorelin vs HCG: LH/FSH-Axis Research Compared

A mechanistic comparison of gonadorelin (synthetic GnRH) and human chorionic gonadotropin (HCG) as research tools for the hypothalamic-pituitary-gonadal axis, covering receptor pharmacology, differential diagnostic applications, regulatory status, and how each compound interrogates a different level of the HPG cascade.

Jun 6, 2026
Abstract immune cell network diagram representing the comparison of Thymosin Alpha-1, Thymulin, and Thymalin thymic peptide research.
Compound Comparison13 min read

Thymosin Alpha-1, Thymulin, and Thymalin: Thymic Peptide Family

A comparative review of three thymic immunomodulatory peptides — Thymosin Alpha-1 (EU-approved, 28-amino acid), Thymulin (zinc-dependent nonapeptide), and Thymalin (bovine thymic extract) — covering mechanism, clinical evidence, and regulatory status.

Jun 5, 2026
Abstract diagram illustrating plasma half-life and peptide degradation kinetics in research settings.
Laboratory Methods7 min read

Understanding Peptide Half-Lives in Research: Degradation, Modification Strategies, and Protocol Timing

A comprehensive reference on peptide plasma half-life: how proteolytic degradation limits peptide stability, the chemical modifications used to extend half-life in research compounds (PEGylation, D-amino acids, cyclization, albumin binding), and implications for in vivo and in vitro experimental design.

Jun 5, 2026

Volumetric Reconstitution Calculator

Enter your vial parameters — the syringe updates live. U-100 and tuberculin configurations.

Quick load:
5 mg
2 mL
250 mcg
Draw
10.0units
0.100 mL  ·  2500 mcg/mL
Config
U-100 Insulin
Open Full Calculator
Syringe Visualization — Live
02040608010010uU-100 (1.0mL)
Vial: 5mgBAC: 2mLDose: 250mcg